These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. Effect of nitric oxide in amyloid fibril formation on transthyretin-related amyloidosis. Saito S; Ando Y; Nakamura M; Ueda M; Kim J; Ishima Y; Akaike T; Otagiri M Biochemistry; 2005 Aug; 44(33):11122-9. PubMed ID: 16101296 [TBL] [Abstract][Full Text] [Related]
8. Amyloid fibril composition and transthyretin gene structure in senile systemic amyloidosis. Gustavsson A; Jahr H; Tobiassen R; Jacobson DR; Sletten K; Westermark P Lab Invest; 1995 Nov; 73(5):703-8. PubMed ID: 7474944 [TBL] [Abstract][Full Text] [Related]
9. Prevalence of germline mutations in the TTR gene in a consecutive series of surgical pathology specimens with ATTR amyloid. Eriksson M; Büttner J; Todorov T; Yumlu S; Schönland S; Hegenbart U; Kristen AV; Dengler T; Lohse P; Helmke B; Schmidt H; Röcken C Am J Surg Pathol; 2009 Jan; 33(1):58-65. PubMed ID: 18830126 [TBL] [Abstract][Full Text] [Related]
10. Distinct characteristics of amyloid deposits in early- and late-onset transthyretin Val30Met familial amyloid polyneuropathy. Koike H; Ando Y; Ueda M; Kawagashira Y; Iijima M; Fujitake J; Hayashi M; Yamamoto M; Mukai E; Nakamura T; Katsuno M; Hattori N; Sobue G J Neurol Sci; 2009 Dec; 287(1-2):178-84. PubMed ID: 19709674 [TBL] [Abstract][Full Text] [Related]
11. Wild-type transthyretin significantly contributes to the formation of amyloid fibrils in familial amyloid polyneuropathy patients with amyloidogenic transthyretin Val30Met. Tsuchiya-Suzuki A; Yazaki M; Kametani F; Sekijima Y; Ikeda S Hum Pathol; 2011 Feb; 42(2):236-43. PubMed ID: 21056899 [TBL] [Abstract][Full Text] [Related]
12. Chameleon 'aggregation-prone' segments of apoA-I: A model of amyloid fibrils formed in apoA-I amyloidosis. Louros NN; Tsiolaki PL; Griffin MD; Howlett GJ; Hamodrakas SJ; Iconomidou VA Int J Biol Macromol; 2015 Aug; 79():711-8. PubMed ID: 26049118 [TBL] [Abstract][Full Text] [Related]
13. Aging and transthyretin-related amyloidosis: pathologic examinations in pulmonary amyloidosis. Ueda M; Ando Y; Haraoka K; Katsuragi S; Terasaki Y; Sugimoto M; Sun X; Uchino M Amyloid; 2006 Mar; 13(1):24-30. PubMed ID: 16690497 [TBL] [Abstract][Full Text] [Related]
14. Amyloid fibrils containing fragmented ATTR may be the standard fibril composition in ATTR amyloidosis. Ihse E; Rapezzi C; Merlini G; Benson MD; Ando Y; Suhr OB; Ikeda S; Lavatelli F; Obici L; Quarta CC; Leone O; Jono H; Ueda M; Lorenzini M; Liepnieks J; Ohshima T; Tasaki M; Yamashita T; Westermark P Amyloid; 2013 Sep; 20(3):142-50. PubMed ID: 23713495 [TBL] [Abstract][Full Text] [Related]
15. Amyloid and nonfibrillar deposits in mice transgenic for wild-type human transthyretin: a possible model for senile systemic amyloidosis. Teng MH; Yin JY; Vidal R; Ghiso J; Kumar A; Rabenou R; Shah A; Jacobson DR; Tagoe C; Gallo G; Buxbaum J Lab Invest; 2001 Mar; 81(3):385-96. PubMed ID: 11310831 [TBL] [Abstract][Full Text] [Related]
16. Amyloidogenic mutations in human apolipoprotein A-I are not necessarily destabilizing - a common mechanism of apolipoprotein A-I misfolding in familial amyloidosis and atherosclerosis. Das M; Mei X; Jayaraman S; Atkinson D; Gursky O FEBS J; 2014 Jun; 281(11):2525-42. PubMed ID: 24702826 [TBL] [Abstract][Full Text] [Related]